These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19468994)

  • 1. Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?
    Colombo E; Latiano A; Palmieri O; Bossa F; Andriulli A; Annese V
    World J Gastroenterol; 2009 May; 15(20):2456-62. PubMed ID: 19468994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Faustini F; Zoli A; Ferraccioli GF
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
    Wang CR; Tsai HW
    World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland.
    Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I
    Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients.
    Conigliaro P; Chimenti MS; Ascolani M; Triggianese P; Novelli L; Onali S; Lolli E; Calabrese E; Petruzziello C; Pallone F; Perricone R; Biancone L
    Autoimmun Rev; 2016 Feb; 15(2):184-90. PubMed ID: 26554932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association].
    Protzer U; Duchmann R; Höhler T; Hitzler W; Ewe K; Wanitschke R; Meyer zum Büschenfelde KH; Märker-Hermann E
    Med Klin (Munich); 1996 Jun; 91(6):330-5. PubMed ID: 8767304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
    de Vlam K; Mielants H; Cuvelier C; De Keyser F; Veys EM; De Vos M
    J Rheumatol; 2000 Dec; 27(12):2860-5. PubMed ID: 11128677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.
    Brophy S; Pavy S; Lewis P; Taylor G; Bradbury L; Robertson D; Lovell C; Calin A
    J Rheumatol; 2001 Dec; 28(12):2667-73. PubMed ID: 11764216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal lesions associated with spondyloarthropathies.
    Orlando A; Renna S; Perricone G; Cottone M
    World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects.
    Mielants H; Veys EM; De Vos M; Cuvelier C; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2266-72. PubMed ID: 8835560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Gyselbrecht L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2279-84. PubMed ID: 8835562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
    Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease.
    Orchard TR; Thiyagaraja S; Welsh KI; Wordsworth BP; Hill Gaston JS; Jewell DP
    Gastroenterology; 2000 Feb; 118(2):274-8. PubMed ID: 10648455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune linkages between inflammatory bowel disease and spondyloarthropathies.
    Baeten D; De Keyser F; Mielants H; Veys EM
    Curr Opin Rheumatol; 2002 Jul; 14(4):342-7. PubMed ID: 12118165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.